Le Lézard
Classified in: Health, Covid-19 virus
Subjects: AWD, SCZ

Brookdale Earns Best of the Best Award from Argentum


Residents and Associates recognized for contributions to the industry

NASHVILLE, Tenn., July 19, 2022 /PRNewswire/ -- Brookdale Senior Living's National Advisory Council (NAC) won a 2022 Argentum Best of the Best Award. The Argentum Best of the Best Awards recognize innovative programs, products and services that solve a particular challenge or advance excellence in senior living.

The NAC provides helpful and timely perspectives and suggestions that help improve and enhance the resident experience. Cindy Baier, Brookdale's President and CEO created the NAC in 2018. The NAC is comprised of residents selected from Brookdale Independent Living communities throughout the United States. Feedback from the NAC was especially insightful during the COVID-19 pandemic.

"We are extremely proud of this recognition," said Baier. "I believe that receiving feedback directly from those that we serve makes Brookdale stronger and helps us further enrich lives."

The Brookdale NAC was recognized in the July/August edition of Senior Living Executive magazine.

About Brookdale Senior Living

Brookdale Senior Living Inc. is the nation's premier operator of senior living communities. The Company is committed to its mission of enriching the lives of the people it serves with compassion, respect, excellence and integrity. The Company operates independent living, assisted living, memory care, and continuing care retirement communities. Through its comprehensive network, Brookdale helps to provide seniors with care and services in an environment that feels like home. The Company's expertise in healthcare, hospitality and real estate provides residents with opportunities to improve wellness, pursue passions and stay connected with friends and loved ones. Brookdale operates and manages 674 communities in 41 states as of June 30, 2022, with the ability to serve more than 60,000 residents. For more Brookdale news, go to brookdalenews.com

Contact: Media Relations, 615-564-8666, [email protected]

 

SOURCE Brookdale Senior Living


These press releases may also interest you

at 11:40
World Anti-obesity Drugs Market Report 2024-2034: Top Anti-obesity Products, Pipeline Analysis by Phase, New Product Launches - ResearchAndMarkets.com
The "Anti-obesity Drugs Market Report 2024-2034" report has been added to ResearchAndMarkets.com's offering. Overall world revenue for Anti-obesity Drugs Market, 2024 to 2034 in terms of value the market, will surpass US$ 78.00 billion in 2034, the...

at 11:05
Baystate Health to build new, state-of-the-art community health center with landmark donation and support from MassMutual
In an effort to improve health equity and meet the growing needs of the Springfield community, Baystate Health today announced a plan to build a comprehensive community health center in the heart of the city, made possible by the generous support of...

at 11:05
United States Pet Market Outlook 2024-2025: Technology Extends Omnimarket Reach with a Projected $190 Billion Industry through 2028 - ResearchAndMarkets.com
The "US Pet Market Outlook, 2024-2025" report has been added to ResearchAndMarkets.com's offering. With the pet industry continuing to trend in omnichannel and omnimarket directions, the publisher anticipates ongoing modest but steady growth across...

at 10:55
Global Glycerol Monostearate Industry Report 2024: $2.09 Billion Market Analysis by Purity, Type, Application & Region 2023-2029 - ResearchAndMarkets.com
The "Global Glycerol Monostearate Market: Analysis By Purity, By Type, By Application, By Region Size & Forecast with Impact Analysis of COVID-19 and Forecast up to 2029" report has been added to ResearchAndMarkets.com's offering. In 2023, the...

at 10:10
Result of AGM
SHELL PLC RESULT OF ANNUAL GENERAL MEETING Shell plc announces the poll results on the resolutions at its Annual General Meeting held on Tuesday May 21, 2024 at the InterContinental London ? The O2, 1 Waterview Drive, Greenwich Peninsula, London...

at 10:05
Alvotech and Dr. Reddy's Enter Into Collaboration for Commercialization of AVT03 (denosumab), a Biosimilar Candidate to Prolia® & Xgeva® in the U.S., Europe and UK
Alvotech , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide ("Alvotech"), and Dr. Reddy's Laboratories SA, wholly-owned subsidiary of Dr. Reddy's Laboratories Ltd., (BSE: 500124 |...

More news about Covid-19 virus...


News published on and distributed by: